Related Experiment Videos
[Leukemia associated with bimkolane]
Abstract:
Psoriatic patients and mice treated with bimolane were observed. The frequency of chromosomes aberration and micro-nuclear cells presence in the treated group (11 cases) was significantly higher than that in the control group (11 cases, P < 0.005; < 0.001). Study of lymphocytic subsets showed that value of CD4/CD8 in the peripheral blood of the treated group was lower than that of the control group (P < 0.05). The level of serum IgM in the treated group was also lower (P < 0.05). There were 10 mice suffering from leukemia (7 mice with acute promyelocytic leukemia) in a treated group of 40 mice of an inbred line of 615 mice, while there was no leukemia in a control group of 20 mice of the same species. The morbidity of leukemia in the treated mice was higher than that of controls (P < 0.05).
Insights
Bimolane treatment increased chromosome aberrations and micro-nuclear cells in psoriatic patients and mice. Leukemia incidence also rose significantly in treated mice, indicating potential genotoxicity and carcinogenicity.
Area of Science:
- Toxicology
- Genetics
- Immunology
Context:
- Psoriasis is an autoimmune disease.
- Bimolane is a therapeutic agent.
Purpose:
- To investigate the genotoxic and carcinogenic effects of bimolane in psoriatic patients and mice.
Summary:
- Bimolane treatment led to a significant increase in chromosome aberrations and micronuclear cells in patients and mice.
- CD4/CD8 ratios and serum IgM levels were reduced in treated patients.
- Leukemia incidence, including acute promyelocytic leukemia, was significantly higher in bimolane-treated mice compared to controls.
Impact:
- Bimolane exhibits genotoxic and potentially carcinogenic properties.
- Findings suggest careful evaluation of bimolane's safety profile for therapeutic use.